Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Licenses Technology from UCSC

NEW YORK (GenomeWeb News) – Oxford Nanopore Technologies has licensed technology developed at the University of California, Santa Cruz, with applications in single-molecule DNA sequencing and molecular sensing, the company said today.
The firm also has agreed to fund research programs conducted by the UCSC scientists who developed the nanopore technology, David Deamer and Mark Akeson.
Oxford Nanopore said its first generation of nanopore sequencing “is poised to be the first label-free DNA sequencing system,” which could offer “a dramatic improvement” in the speed and cost of sequencing.
“A label-free approach to DNA sequencing would facilitate a transformation in genomics that could be likened to the broadband revolution," Oxford Nanopore CEO Gordon Sanghera said in a statement.
The agreement with UCSC follows a deal that the company announced earlier this month in which it licensed intellectual property related to nanopore technology from Harvard University.
The Harvard agreement included “some discoveries” from UCSC, Oxford Nanopore said.
The company also said today that it has formed a technical advisory board that is composed of nanopore researchers, including Deamer and Akeson, who will help the company develop its BASE sequencing technology, which combines a biological nanopore with a processive enzyme arrayed on a silicon chip. The company said its future sequencing technologies could involve solid-state nanopores, or may analyze single stranded nucleic acids.
Financial terms of the agreement were not released.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.